IL-1β, as a marker of NLRP3 inflammasome activation, is positively correlated with MMP9 and negatively correlated with E-cadherin, suggesting that IL-1β is involved in EMT and promotes the development of cancer (Marandi et al., 2021). This evidence concerns the gene IL1B and cancer.